Previous close | 150.41 |
Open | 150.41 |
Bid | 135.70 |
Ask | 144.00 |
Strike | 330.00 |
Expiry date | 2026-01-16 |
Day's range | 150.41 - 150.41 |
Contract range | N/A |
Volume | |
Open interest | 10 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
The S&P 500 was quiet again, but Toast led several new buys. Robinhood and Arm were big earnings movers late.